Prometheon Pharma, LLC
Breakthrough product, $20B/year initial market, and expert team, with a business model providing revenue prior to product launch.
Featured on CNBC: www.bit.ly/ppcnbc
Patented platform technology, initial $15B/yr market. De-risked partnership model that allows big pharma to test our technology for $100k with virtually no risk to them and high margins for us. We are close to closing the first such deal with a global company.
We have delivered insulin, IGF-1 for hair regrowth, and hGH. We are outlicensing/selling the hair growth product to fund internal development in 2015.